IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank38
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P38
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$-71.10M+71.3%
2024$-247.58M-114.9%
2023$-115.22M-32.2%
2022$-87.17M-56.3%
2021$-55.78M-200.6%
2020$55.46M+241.1%
2019$-39.31M-42.3%
2018$-27.62M-125.9%
2017$-12.22M-